I just left from speaking with quest about their upcoming clinical trial for Gen-003 and its exciting to be apart of such an amazing study. They are looking for individuals to join, if you're interested please contact Laura using the information below.
Dear Quest HSV-2 List,
We are very excited to share with you the latest update from the Genocea HSV vaccine study.
The announcement, released last week, confirmed that 6 months after their last dose of vaccine, study patients who received the optimal dose sustained a viral shedding rate reduction of 58%. The complete press release is available here.
As we begin to screen folks for the next program, we would like to express our deepest gratitude to those of you whose efforts and participation have made all of this possible.
If you are interested in participating in the GEN-003-003 trial, or have any referrals you’d like to make for this next phase, please contact Laura Holland at 415-353-0800 / laura@questclinical.com
Best,
Dr. Jay